Daniel Kraft is a Stanford and Harvard-trained physician-scientist, inventor, entrepreneur, and investor. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as faculty chair for Medicine at Singularity University since its inception in 2008 and is founder and chair of NextMed Health (the evolution of Exponential Medicine), a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.

 

Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and Stanford fellowships in hematology, oncology, and bone marrow transplantation.

 

He has multiple scientific publications (including in Nature and Science) and medical device, immunology, and stem cell-related patents through NIH-funded faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at the University of California San Francisco. 

 

Daniel is a member of the Inaugural class of the Aspen Institute Health Innovators Fellowship and is a member of the Kauffman Fellows Society. Daniel is a partner with Continuum Health Ventures, investing in seed-stage digital health startups. He serves as chair of the XPRIZE Pandemic & Health Alliance. He is often called upon to speak to the future of health, medicine and technology and has given four TED and two TEDMED Talks and has delivered keynotes to a diverse array of organizations. 

He is heavily involved in digital health, founded Digital.Health, is on the board of Healthy.io and advises several Fortune-50 and digital health-related startups. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies. 

Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.